Bernard Ross, CEO and Founder of Sky Medical commented;
"Thank you Medilink. We are extremely proud to again be recognised, this time with the prestigious Innovation Award. Not only does it celebrate world-class design and our mission to make prevention easy in stopping life threatening blood clots, it also recognises the high priority we place on partnering with our NHS colleagues who, on top of their full-time jobs, and in a challenging environment, are willing to give-up additional time in pursuit of innovation for the improvement of patient care."
You can read more about the award here.
By following this link, you will leave the Deepbridge website. Deepbridge takes no responsibility for content on external websites.
About Sky Medical Technology
Sky Medical Technology Ltd has developed the OnPulseTM technology platform, which has been proven to significantly improve blood ﬂow (both volume and velocity). The results indicate that the platform can be used across a variety of indications, challenging both pharmaceutical and device solutions on the market today.
The primary initial applications for the technology are:
- Prevention and treatment of Deep Vein Thrombosis (DVT);
- Surgical recovery;
- Chronic wound care (of ‘hard to heal’ wounds); and
- Elite sports recovery.